Cibc World Market Inc. Makes New $3.81 Million Investment in Agilent Technologies, Inc. $A

Cibc World Market Inc. acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 28,711 shares of the medical research company’s stock, valued at approximately $3,814,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Norges Bank bought a new position in Agilent Technologies during the fourth quarter valued at $549,158,000. Bank of New York Mellon Corp increased its holdings in shares of Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after buying an additional 2,440,360 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after buying an additional 1,652,244 shares during the last quarter. Ameriprise Financial Inc. raised its position in shares of Agilent Technologies by 132.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after buying an additional 1,340,161 shares in the last quarter. Finally, Findlay Park Partners LLP bought a new position in shares of Agilent Technologies in the 2nd quarter valued at about $174,281,000.

Wall Street Analyst Weigh In

A has been the subject of a number of recent research reports. Sanford C. Bernstein initiated coverage on Agilent Technologies in a report on Friday, June 26th. They issued an “outperform” rating and a $155.00 target price for the company. Barclays increased their price target on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. TD Cowen raised their price target on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Finally, Piper Sandler initiated coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective on the stock. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $160.24.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the roughly $1.84 billion consensus estimate. Adjusted EPS of $1.62 exceeded estimates near $1.48-$1.49 and rose from $1.37 a year earlier. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability and cash generation strengthened. Operating profit increased 23.3% to $444 million, operating cash flow rose 43.4% to $519 million, and the company ended the quarter with $1.8 billion in cash. GAAP net income reached $362 million, or $1.28 per diluted share, versus $336 million, or $1.18, a year earlier. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Agilent raised fiscal 2026 adjusted EPS guidance to $6.18-$6.21, above the approximately $6.06 consensus, and projected revenue of about $7.5 billion versus expectations near $7.4 billion. Management cited improving laboratory-tools demand. Fourth-quarter guidance was broadly in line with analyst estimates. Agilent Raises Annual Profit Forecast
• Neutral Sentiment: Institutional investor positioning was mixed: 594 investors increased holdings in the latest quarter, while 550 reduced positions. Recent analyst targets have a median of $155, suggesting limited near-term upside relative to the recent trading level.
• Negative Sentiment: Despite the earnings beat, Agilent trades at a relatively demanding valuation, with a P/E ratio above 31, and the stock is close to its 12-month high. This could make the shares more sensitive to any slowdown in laboratory-equipment demand or future guidance disappointments.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $155.16 on Thursday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The stock has a market cap of $43.82 billion, a price-to-earnings ratio of 31.16, a price-to-earnings-growth ratio of 2.73 and a beta of 1.25. The firm has a 50-day moving average of $139.16 and a two-hundred day moving average of $126.65. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.51.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same period last year, the company posted $1.37 earnings per share. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, research analysts forecast that Agilent Technologies, Inc. will post 6.05 earnings per share for the current year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.